Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Doelker

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Microencapsulation|February 17, 1998
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion techniqueD Quintanar-Guerrero, A Ganem-Quintanar, E Allémann, et al.
Journal of Drug Targeting|August 12, 2000
Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymersF De Jaeghere, E Allemann, J Feijen, et al.
Pharmaceutical Development and Technology|December 8, 2000
Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticlesF De Jaeghere, E Allémann, J Feijen, et al.
Journal of Biomedical Materials Research|November 1, 1989
Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery systemF Lescure, R Gurny, E Doelker, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2000
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateF De Jaeghere, E Allémann, F Kubel, et al.
Pharmaceutica Acta Helvetiae|December 1, 1995
In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glyceridesA C Vial-Bernasconi, P Buri, E Doelker, et al.
Pharmaceutical Research|July 9, 1999
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptakeF De Jaeghere, E Allémann, J C Leroux, et al.
Journal of Pharmaceutical Sciences|December 1, 1995
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to miceJ C Leroux, R Cozens, J L Roesel, et al.
Pharmaceutica Acta Helvetiae|August 13, 1998
Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenololN Rouge, E Allémann, M Gex-Fabry, et al.
Journal of Biomedical Materials Research|April 1, 1994
Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particlesJ C Leroux, P Gravel, L Balant, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Microencapsulation|February 17, 1998
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion techniqueD Quintanar-Guerrero, A Ganem-Quintanar, E Allémann, et al.
Journal of Drug Targeting|August 12, 2000
Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymersF De Jaeghere, E Allemann, J Feijen, et al.
Pharmaceutical Development and Technology|December 8, 2000
Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticlesF De Jaeghere, E Allémann, J Feijen, et al.
Journal of Biomedical Materials Research|November 1, 1989
Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery systemF Lescure, R Gurny, E Doelker, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2000
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateF De Jaeghere, E Allémann, F Kubel, et al.
Pharmaceutica Acta Helvetiae|December 1, 1995
In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glyceridesA C Vial-Bernasconi, P Buri, E Doelker, et al.
Pharmaceutical Research|July 9, 1999
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptakeF De Jaeghere, E Allémann, J C Leroux, et al.
Journal of Pharmaceutical Sciences|December 1, 1995
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to miceJ C Leroux, R Cozens, J L Roesel, et al.
Pharmaceutica Acta Helvetiae|August 13, 1998
Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenololN Rouge, E Allémann, M Gex-Fabry, et al.
Journal of Biomedical Materials Research|April 1, 1994
Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particlesJ C Leroux, P Gravel, L Balant, et al.
Pageof 6